Cargando…
Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452245/ https://www.ncbi.nlm.nih.gov/pubmed/32875042 http://dx.doi.org/10.1016/j.jdcr.2020.07.005 |
_version_ | 1783575131761672192 |
---|---|
author | Brumfiel, Caitlin M. Saardi, Karl M. Ronkainen, Sanna D. Shenoy, Aarthi G. |
author_facet | Brumfiel, Caitlin M. Saardi, Karl M. Ronkainen, Sanna D. Shenoy, Aarthi G. |
author_sort | Brumfiel, Caitlin M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7452245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-74522452020-08-31 Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases Brumfiel, Caitlin M. Saardi, Karl M. Ronkainen, Sanna D. Shenoy, Aarthi G. JAAD Case Rep Case Report Elsevier 2020-07-12 /pmc/articles/PMC7452245/ /pubmed/32875042 http://dx.doi.org/10.1016/j.jdcr.2020.07.005 Text en © 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Brumfiel, Caitlin M. Saardi, Karl M. Ronkainen, Sanna D. Shenoy, Aarthi G. Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases |
title | Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases |
title_full | Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases |
title_fullStr | Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases |
title_full_unstemmed | Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases |
title_short | Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases |
title_sort | alemtuzumab as initial therapy for sézary syndrome: a report of 2 cases |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452245/ https://www.ncbi.nlm.nih.gov/pubmed/32875042 http://dx.doi.org/10.1016/j.jdcr.2020.07.005 |
work_keys_str_mv | AT brumfielcaitlinm alemtuzumabasinitialtherapyforsezarysyndromeareportof2cases AT saardikarlm alemtuzumabasinitialtherapyforsezarysyndromeareportof2cases AT ronkainensannad alemtuzumabasinitialtherapyforsezarysyndromeareportof2cases AT shenoyaarthig alemtuzumabasinitialtherapyforsezarysyndromeareportof2cases |